Jonathan Sockolosky, PhD

Co-founder and CEO at Macaw Therapeutics

Speaker

Jonathan is Co-Founder and CEO of Macaw Therapeutics, a biotechnology company building antibody therapies that aim to induce durable remission in chronic inflammatory diseases. What drives him is turning ideas into medicines — work he has done as a scientist, an investor, and a founder. His career spans antibodies, cytokines, cell therapies, and receptor-mediated drug delivery, with research, leadership, and venture capital roles at Genentech, ALX Oncology, Denali Therapeutics, and Curie.Bio. He has contributed to three clinical-stage drugs, including one approved medicine. Dr. Sockolosky holds a BS/MS in Biomedical Engineering from the University of Michigan and a PhD in Pharmaceutical Sciences from UCSF, and completed postdoctoral research at Stanford.